Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2005
03/09/2005EP0842273B1 Receptor ligand vegf-c
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005EP0779076B1 Peptide, a method of obtaining it and a pharmaceutical compound based on it
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592638A Promoters exhibiting endothelial cell specificity and methods of using same
03/09/2005CN1592627A Carbon dioxide compositions for external use and process for producing the same
03/09/2005CN1590408A Preparation technology of globe fish peptide and its medical health care use
03/09/2005CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof
03/09/2005CN1589908A Tenascin-C nucleic acid ligands
03/09/2005CN1589905A Medical composition for treating desmosis and its use
03/09/2005CN1589890A Urticaria liniment
03/09/2005CN1589878A Medicine for treating dermatosis and its preparation method
03/09/2005CN1589874A External use traditional Chinese medicine for treating beriberi
03/09/2005CN1589871A Fumigation medicine for treating beriberi
03/09/2005CN1589849A Method for treating psora
03/09/2005CN1589831A Miao nationality medicine ointment for treating skin disease
03/09/2005CN1589821A Oral capsule for fast treating
03/09/2005CN1589820A Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
03/09/2005CN1589818A Internal and external dual purpose Chinese medicine
03/09/2005CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit
03/09/2005CN1191844C Smelling treated Chinese medicine
03/09/2005CN1191834C Aciclovir compositions contg. dimethicone
03/09/2005CN1191826C Pharmaceutical formulation
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864284 Ascorbic acid compounds, methods of synthesis and application use thereof
03/08/2005US6864274 Allantoin-containing skin cream
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/08/2005CA2480712A1 Chondrocyte therapeutic delivery system
03/08/2005CA2230723C Non-ionic amphiphilic lipid and aminosilicone nanoemulsion and its uses
03/08/2005CA2105230C Pharmaceutical or cosmetic composition containing peroxidase associated with an anti-oxygen singlet agent
03/03/2005WO2005019219A1 Pyrrolopyrimidinone derivative
03/03/2005WO2005019218A1 Pyrrolopyrimidinethione derivative
03/03/2005WO2005019197A1 Chromen-4-one derivatives
03/03/2005WO2005019188A1 Fused pyrimidine derivative and use thereof
03/03/2005WO2005018653A1 Oral skin care composition
03/03/2005WO2005018648A1 (20S)-1α-HYDROXY-2-METHYLENE-19-NOR-VITAMIN D3 AND ITS USES
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005WO2003080110A8 Topical pathogenic-tissue-destroying liquid
03/03/2005US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same
03/03/2005US20050049380 Protective coating containing acrylated ester copolymer
03/03/2005US20050049303 Adamantane derivatives
03/03/2005US20050049294 Methods of using [3.2.0] heterocyclic compounds and analogs thereof
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049282 Process
03/03/2005US20050049268 Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentation
03/03/2005US20050049261 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives
03/03/2005US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
03/03/2005US20050049251 Inhibitors of p38
03/03/2005US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine
03/03/2005US20050049241 Vanilloid receptor antagonists; acute or chronic pain, itching; inflammation; gastrointestinal and urinary tract disorders; tracheobronchial and diaphragmatic dysfunction
03/03/2005US20050049238 Heterocyclic retinoid compounds
03/03/2005US20050049232 Preventing hair loss and/or stimulating growth; active ingredient combined with lipophilic and hydrophilic two phase system; creates semipermeable membrane in skin holding medication in appropriate area; reduced irritation and systemic effects
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis
03/03/2005US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides
03/03/2005US20050049189 Immunosuppressive protein for use in treatment and prevention of allergic, autoimmune, skin and respiratory disorders
03/03/2005US20050049182 Therapeutic formulation comprising cationic peptide, viscosity-increasing agent, and solvent, wherein the cationic peptide contains up to 35 amino acids; use in treating or preventing infectious disease associated with foreign bodies, primary or seconary infection sites
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy
03/03/2005US20050048138 Use of Rhodiola crenulata extract via the topical route
03/03/2005US20050048134 Therapy, prevention of papillomavirus infections; antiinflammatory agents; wound healing agents
03/03/2005US20050048128 Using ascorbic acid and petroleum jelly
03/03/2005US20050048101 Plaster for topical use containing heparin and diclofenac
03/03/2005US20050048055 Use of CD40 engagement to alter T cell receptor usage
03/03/2005US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
03/03/2005US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine
03/03/2005US20050047958 Methods for sterilizing preparations of digestive enzymes
03/03/2005CA2536313A1 Fused pyrimidine derivative and use thereof
03/03/2005CA2535571A1 Composition for treatment of tinea pedis and method of use
03/03/2005CA2535516A1 Silencing of tgf-beta receptor type ii expression by sirna
03/02/2005EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1510511A1 Gingerol analogues and use thereof
03/02/2005EP1510225A2 Photochemotherapeutic and diagnostic application using 5-ALA and precursors
03/02/2005EP1510224A1 In vivo gene transfer methods for wound healing
03/02/2005EP1510221A1 Preventives and/or remedies for subjects with the expression or activation of her2 and/or egfr
03/02/2005EP1510217A1 An anti-rheumatism medicament and method to prepare thereof
03/02/2005EP1510211A1 Pharmaceutical composition comprising N-retinyl-N-retinylidene Ethanolamine (A2E), isoforms of A2E or derivatives thereof
03/02/2005EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/02/2005EP1509597A2 Hair follicle mesenchymal stem cells and use thereof
03/02/2005EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof
03/02/2005EP1509521A2 1h-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases
03/02/2005EP1509515A2 Substituted 4-aryl-4h-pyrrolo 2,3-h chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/02/2005EP1509506A1 Pyridazine derivatives
03/02/2005EP1509501A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
03/02/2005EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
03/02/2005EP1509249A2 Inclusion complexes of rosiglitazone
03/02/2005EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis
03/02/2005EP1509236A2 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions
1 ... 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 ... 1065